miR-122 negatively correlates with liver fibrosis as detected by histology and FibroScan

microRNA expression might predict prognosis of epithelial hepatoblastoma

(2014) Mónika Gyugos et al.   VIRCHOWS ARCHIV

Elevated miR-33a and miR-224 in steatotic chronic hepatitis C liver biopsies

(2014) Gabor Lendvai   WORLD JOURNAL OF GASTROENTEROLOGY

MicroRNA-21 activates hepatic stellate cells via PTEN/Akt signaling

(2013) Jun Wei et al.   BIOMEDICINE & PHARMACOTHERAPY

Liver fibrosis staging through a stepwise analysis of non-invasive markers (FibroSteps) in patients with chronic hepatitis C infection

(2013) Samer S. El-Kamary et al.   LIVER INTERNATIONAL

p53/mdm2 Feedback Loop Sustains miR-221 Expression and Dictates the Response to Anticancer Treatments in Hepatocellular Carcinoma

(2013) Francesca Fornari et al.   MOLECULAR CANCER RESEARCH

MicroRNAs in liver disease

(2013) Gyongyi Szabo et al.   Nature Reviews Gastroenterology & Hepatology

Unconventional miR-122 binding stabilizes the HCV genome by forming a trimolecular RNA structure

(2013) Stefanie A. Mortimer et al.   NUCLEIC ACIDS RESEARCH

A New Strategy for Treatment of Liver Fibrosis

(2012) Shao-Long Chen et al.   BIODRUGS

The potential of microRNAs in liver fibrosis

(2012) Yong He et al.   CELLULAR SIGNALLING

Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis

(2012) Ashley M. Lakner et al.   HEPATOLOGY

Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model

(2012) Elisa Callegari et al.   HEPATOLOGY

MicroRNA-221 overexpression accelerates hepatocyte proliferation during liver regeneration

(2012) Qinggong Yuan et al.   HEPATOLOGY

Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma

(2012) Florie Borel et al.   JOURNAL OF HEPATOLOGY

miR-122 acts as a tumor suppressor in hepatocarcinogenesis in vivo

(2012) Mirjam B. Zeisel et al.   JOURNAL OF HEPATOLOGY

miR-122 regulates collagen production via targeting hepatic stellate cells and suppressing P4HA1 expression

(2012) Jiang Li et al.   JOURNAL OF HEPATOLOGY

MiR-122 in hepatic function and liver diseases

(2012) Jun Hu et al.   Protein & Cell

microRNA are Central Players in Anti- and Profibrotic Gene Regulation during Liver Fibrosis

(2012) Andrea Noetel et al.   Frontiers in Physiology

MicroRNAs as biomarkers of disease onset

(2011) Maciej Ciesla et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Mechanisms of hepatic fibrogenesis

(2011) Ursula E. Lee et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches

(2011) Elisabetta Mormone et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Two-tiered Approach Identifies a Network of Cancer and Liver Disease-related Genes Regulated by miR-122

(2011) Daniel R. Boutz et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Transcriptional regulation of miR-224 upregulated in human HCCs by NFκB inflammatory pathways

(2011) Cecilia Scisciani et al.   JOURNAL OF HEPATOLOGY

Hepatitis C Virus Infection and Hepatic Stellate Cell Activation Downregulate miR-29: miR-29 Overexpression Reduces Hepatitis C Viral Abundance in Culture

(2011) Sarmistha Bandyopadhyay et al.   JOURNAL OF INFECTIOUS DISEASES

How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography vs. liver biopsy?

(2011) Laurent Castera et al.   LIVER INTERNATIONAL

Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance

(2011) Andreas Karakatsanis et al.   MOLECULAR CARCINOGENESIS

Hepatocyte Growth Factor (HGF) Inhibits Collagen I and IV Synthesis in Hepatic Stellate Cells by miRNA-29 Induction

(2011) Monika Kwiecinski et al.   PLoS One

Serum MicroRNA-21 as Marker for Necroinflammation in Hepatitis C Patients with and without Hepatocellular Carcinoma

(2011) Verena Bihrer et al.   PLoS One

The parallel universe: microRNAs and their role in chronic hepatitis, liver tissue damage and hepatocarcinogenesis

(2011) J Haybaeck et al.   SWISS MEDICAL WEEKLY

MicroRNAs and liver disease

(2011) Thomas A. Kerr et al.   Translational Research

microRNAs: Fad or future of liver disease

(2011) Ashley M Lakner   WORLD JOURNAL OF GASTROENTEROLOGY

Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy

(2010) Jiannis Anastasiou et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans

(2010) Rebecca T Marquez et al.   LABORATORY INVESTIGATION

Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C

(2010) Kazutoyo Morita et al.   LIVER INTERNATIONAL

Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation

(2009) Juling Ji et al.   FEBS LETTERS

Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice

(2009) Bo Wang et al.   HEPATOLOGY

MicroRNAs: Potential biomarkers for cancer diagnosis, prognosis and targets for therapy

(2009) William C.S. Cho   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

miR-221 overexpression contributes to liver tumorigenesis

(2009) P. Pineau et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MicroRNA involvement in hepatocellular carcinoma

(2008) Laura Gramantieri et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Evaluation and Validation of Total RNA Extraction Methods for MicroRNA Expression Analyses in Formalin-Fixed, Paraffin-Embedded Tissues

(2008) Martina Doleshal et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma

(2008) F Fornari et al.   ONCOGENE